Suppr超能文献

蛋白质精氨酸甲基转移酶:在原子水平上对酶结构和机制的深入了解。

Protein arginine methyltransferases: insights into the enzyme structure and mechanism at the atomic level.

机构信息

Institute of Biological Chemistry, Academia Sinica, Taipei, 115, Taiwan.

College of Pharmacy, University of Georgia, Athens, GA, 30602, USA.

出版信息

Cell Mol Life Sci. 2019 Aug;76(15):2917-2932. doi: 10.1007/s00018-019-03145-x. Epub 2019 May 23.

Abstract

Protein arginine methyltransferases (PRMTs) catalyze the methyl transfer to the arginine residues of protein substrates and are classified into three major types based on the final form of the methylated arginine. Recent studies have shown a strong correlation between PRMT expression level and the prognosis of cancer patients. Currently, crystal structures of eight PRMT members have been determined. Kinetic and structural studies have shown that all PRMTs share similar, but unique catalytic and substrate recognition mechanism. In this review, we discuss the structural similarities and differences of different PRMT members, focusing on their overall structure, S-adenosyl-L-methionine-binding pocket, substrate arginine recognition and catalytic mechanisms. Since PRMTs are valuable targets for drug discovery, we also rationally classify the known PRMT inhibitors into five classes and discuss their mechanisms of action at the atomic level.

摘要

蛋白精氨酸甲基转移酶(PRMTs)催化将甲基转移到蛋白质底物的精氨酸残基上,并根据甲基化精氨酸的最终形式分为三大类。最近的研究表明,PRMT 的表达水平与癌症患者的预后有很强的相关性。目前已经确定了 8 个 PRMT 成员的晶体结构。动力学和结构研究表明,所有 PRMT 都具有相似但独特的催化和底物识别机制。在这篇综述中,我们讨论了不同 PRMT 成员的结构相似性和差异性,重点讨论了它们的整体结构、S-腺苷甲硫氨酸结合口袋、底物精氨酸识别和催化机制。由于 PRMTs 是药物发现的有价值的靶点,我们还将已知的 PRMT 抑制剂合理地分为五类,并在原子水平上讨论它们的作用机制。

相似文献

1
Protein arginine methyltransferases: insights into the enzyme structure and mechanism at the atomic level.
Cell Mol Life Sci. 2019 Aug;76(15):2917-2932. doi: 10.1007/s00018-019-03145-x. Epub 2019 May 23.
2
Mechanisms and Inhibitors of Histone Arginine Methylation.
Chem Rec. 2018 Dec;18(12):1792-1807. doi: 10.1002/tcr.201800082. Epub 2018 Sep 19.
3
Peptidic transition state analogues as PRMT inhibitors.
Methods. 2020 Mar 15;175:24-29. doi: 10.1016/j.ymeth.2019.08.003. Epub 2019 Aug 14.
4
Biochemistry and regulation of the protein arginine methyltransferases (PRMTs).
Arch Biochem Biophys. 2016 Jan 15;590:138-152. doi: 10.1016/j.abb.2015.11.030. Epub 2015 Dec 2.
6
Protein arginine N-methyltransferase substrate preferences for different nη-substituted arginyl peptides.
Chembiochem. 2014 Jul 21;15(11):1607-13. doi: 10.1002/cbic.201402045. Epub 2014 Jul 8.
7
Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
J Biol Chem. 2016 Dec 23;291(52):26722-26738. doi: 10.1074/jbc.M116.757625. Epub 2016 Nov 10.
8
Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.
Pharmacol Ther. 2007 Jan;113(1):50-87. doi: 10.1016/j.pharmthera.2006.06.007. Epub 2006 Sep 26.
9
Protein Arginine Methyltransferase Product Specificity Is Mediated by Distinct Active-site Architectures.
J Biol Chem. 2016 Aug 26;291(35):18299-308. doi: 10.1074/jbc.M116.740399. Epub 2016 Jul 7.

引用本文的文献

1
Emerging roles of protein arginine methyltransferase in multiple myeloma.
Mol Ther Oncol. 2025 May 26;33(2):201003. doi: 10.1016/j.omton.2025.201003. eCollection 2025 Jun 18.
2
Functional Dynamics of Arginine Mono- and Di-Methylation.
Cells. 2025 May 29;14(11):796. doi: 10.3390/cells14110796.
3
PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C-Myc Feedback Loop.
MedComm (2020). 2025 May 15;6(6):e70150. doi: 10.1002/mco2.70150. eCollection 2025 Jun.
4
MTA-cooperative PRMT5 inhibitors from cofactor-directed DNA-encoded library screens.
Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2425052122. doi: 10.1073/pnas.2425052122. Epub 2025 May 16.
5
Protein Arginine Methyltransferases from Regulatory Function to Clinical Implication in Central Nervous System.
Cell Mol Neurobiol. 2025 May 14;45(1):41. doi: 10.1007/s10571-025-01546-0.
7
PRMT3 and CARM1: Emerging Epigenetic Targets in Cancer.
J Cell Mol Med. 2025 Feb;29(4):e70386. doi: 10.1111/jcmm.70386.
10
PRMT5 Inhibitor EPZ015666 Decreases the Viability and Encystment of .
Molecules. 2024 Dec 27;30(1):62. doi: 10.3390/molecules30010062.

本文引用的文献

1
Mechanisms and Inhibitors of Histone Arginine Methylation.
Chem Rec. 2018 Dec;18(12):1792-1807. doi: 10.1002/tcr.201800082. Epub 2018 Sep 19.
2
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.
ACS Med Chem Lett. 2018 Apr 23;9(7):612-617. doi: 10.1021/acsmedchemlett.8b00014. eCollection 2018 Jul 12.
3
Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery.
J Med Chem. 2018 Nov 8;61(21):9429-9441. doi: 10.1021/acs.jmedchem.8b00598. Epub 2018 Jun 20.
4
Hijacking DNA methyltransferase transition state analogues to produce chemical scaffolds for PRMT inhibitors.
Philos Trans R Soc Lond B Biol Sci. 2018 Jun 5;373(1748). doi: 10.1098/rstb.2017.0072.
5
Cryo-electron microscopy structure of a human PRMT5:MEP50 complex.
PLoS One. 2018 Mar 8;13(3):e0193205. doi: 10.1371/journal.pone.0193205. eCollection 2018.
6
Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3).
J Med Chem. 2018 Feb 8;61(3):1204-1217. doi: 10.1021/acs.jmedchem.7b01674. Epub 2018 Jan 5.
7
Identification and structural analysis of protein arginine methyltransferase 4 (PRMT4).
FEBS Open Bio. 2017 Oct 10;7(12):1909-1923. doi: 10.1002/2211-5463.12323. eCollection 2017 Dec.
8
Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases.
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10101-10106. doi: 10.1073/pnas.1706978114. Epub 2017 Sep 5.
9
Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.
Medchemcomm. 2017 Feb 1;8(2):440-444. doi: 10.1039/C6MD00573J. Epub 2017 Jan 3.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验